Read top takeaways from members of the CF community
Cystic Fibrosis Foundation
4550 Montgomery Avenue, Suite 1100N
Bethesda, MD | 20814 US
www.cff.org ([link removed])
([link removed])
Thank you for joining us for this year’s North American Cystic Fibrosis Conference! Together, we were more than 5,000 researchers, clinicians, and community members strong hearing the latest on cystic fibrosis research, care, and drug development.
Read the CF Community Blog ([link removed]) to catch up on some of the highlights from this year's plenaries at NACFC.
How CF Care Adapted to Meet the Challenges Posed by COVID-19
The COVID-19 pandemic brought great challenges to providing CF care. Following plenary one, “Meeting the Moment: Lessons for a Changing World,” Jennifer Gell, a parent to two children with cystic fibrosis, shares her top takeaways ([link removed]) about how care teams adapted to meet the challenges posed by the pandemic and where CF care may be headed in the future.
Read Jennifer’s blog » ([link removed])
Watch Plenary 1 on Facebook Live » ([link removed])
Expanding the Scientific Frontier to the Next Generation of Therapies
Developing genetic therapies – especially those as complex as gene editing – will take a long time and a lot of collaboration. Following plenary two, “Working Together to Pave the Path to a Cure,” Art Brace, a scientist and an adult with CF, shares the key moments ([link removed]) that resonated with him from each of the scientists’ presentations.
Read Art’s blog » ([link removed])
Watch Plenary 2 on Facebook Live » ([link removed])
Expanding Treatment Options for Everyone Who Has CF
After the final plenary of NACFC, “Expanding the Horizon of Therapies for the Underlying Cause of CF,” Xan Nowakowski, a scientist and an adult with cystic fibrosis, reflects on the need for expanding treatment options ([link removed]) for everyone living with CF.
Read Xan’s blog » ([link removed])
Watch Plenary 3 on Facebook Live » ([link removed])
4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US
This email was sent to
[email protected].
To ensure that you continue receiving our emails,
please add us to your address book or safe list.
manage your preferences ([link removed])
opt out ([link removed]) using TrueRemove(r).
Got this as a forward? Sign up ([link removed]) to receive our future emails.